Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Silverberg

Showing results (11-20 of 228) with videos related to

Pageof 23
Sort By:
ACG Case Reports Journal|October 17, 2019
Correction: Colonic Vascular Prominence From Superior Mesenteric Vein OcclusionThurarshen Jeyalingam, Kevin Pivovarov, Mark S Silverberg
Molecular Diagnosis & Therapy|August 29, 2009
The future of molecular approaches to inflammatory bowel diseaseBoyko Kabakchiev, Smita Halder, Mark S Silverberg
ACG Case Reports Journal|December 5, 2019
Colonic Vascular Prominence From Superior Mesenteric Vein OcclusionThurarshen Jeyalingam, Kevin Pivovarov, Mark S Silverberg
Gastroenterology|August 18, 2020
What Constitutes Frailty In Inflammatory Bowel Disease?Margaret Walshe, Mark S Silverberg, Laura E Targownik
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic reviewTravis Murdoch, Sarah O'Donnell, Mark S Silverberg, et al.
The American Journal of Gastroenterology|April 23, 2014
Analyzing the human microbiome: a "how to" guide for physiciansAndrea D Tyler, Michelle I Smith, Mark S Silverberg
Inflammatory Bowel Diseases|April 27, 2018
Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel DiseaseTomer Greener, Boyko Kabakchiev, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|April 17, 2018
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative ColitisDavid Kevans, Sanjay Murthy, Diane R Mould, et al.
Journal of Crohn'S & Colitis|January 3, 2018
The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's DiseaseTomer Greener, Karen Boland, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|June 28, 2015
Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's diseaseSarah O'Donnell, Joanne M Stempak, A Hillary Steinhart, et al.
Pageof 23

Showing results (11-20 of 228) with videos related to

Sort By:
Pageof 23
ACG Case Reports Journal|October 17, 2019
Correction: Colonic Vascular Prominence From Superior Mesenteric Vein OcclusionThurarshen Jeyalingam, Kevin Pivovarov, Mark S Silverberg
Molecular Diagnosis & Therapy|August 29, 2009
The future of molecular approaches to inflammatory bowel diseaseBoyko Kabakchiev, Smita Halder, Mark S Silverberg
ACG Case Reports Journal|December 5, 2019
Colonic Vascular Prominence From Superior Mesenteric Vein OcclusionThurarshen Jeyalingam, Kevin Pivovarov, Mark S Silverberg
Gastroenterology|August 18, 2020
What Constitutes Frailty In Inflammatory Bowel Disease?Margaret Walshe, Mark S Silverberg, Laura E Targownik
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic reviewTravis Murdoch, Sarah O'Donnell, Mark S Silverberg, et al.
The American Journal of Gastroenterology|April 23, 2014
Analyzing the human microbiome: a "how to" guide for physiciansAndrea D Tyler, Michelle I Smith, Mark S Silverberg
Inflammatory Bowel Diseases|April 27, 2018
Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel DiseaseTomer Greener, Boyko Kabakchiev, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|April 17, 2018
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative ColitisDavid Kevans, Sanjay Murthy, Diane R Mould, et al.
Journal of Crohn'S & Colitis|January 3, 2018
The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's DiseaseTomer Greener, Karen Boland, A Hillary Steinhart, et al.
Journal of Crohn'S & Colitis|June 28, 2015
Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's diseaseSarah O'Donnell, Joanne M Stempak, A Hillary Steinhart, et al.
Pageof 23